These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19764141)

  • 1. [Vasopressin for treatment of shock].
    Carrillo-Esper R; Calvo-Carrillo B
    Cir Cir; 2003; 71(2):129-36. PubMed ID: 19764141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin decreases intestinal mucosal perfusion: a clinical study on cardiac surgery patients in vasodilatory shock.
    Nygren A; Thorén A; Ricksten SE
    Acta Anaesthesiol Scand; 2009 May; 53(5):581-8. PubMed ID: 19239407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock.
    Tsuneyoshi I; Yamada H; Kakihana Y; Nakamura M; Nakano Y; Boyle WA
    Crit Care Med; 2001 Mar; 29(3):487-93. PubMed ID: 11373409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of short-term vasopressin infusion during severe septic shock.
    Patel BM; Chittock DR; Russell JA; Walley KR
    Anesthesiology; 2002 Mar; 96(3):576-82. PubMed ID: 11873030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent.
    Argenziano M; Chen JM; Choudhri AF; Cullinane S; Garfein E; Weinberg AD; Smith CR; Rose EA; Landry DW; Oz MC
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):973-80. PubMed ID: 9832689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis.
    Dünser MW; Mayr AJ; Ulmer H; Ritsch N; Knotzer H; Pajk W; Luckner G; Mutz NJ; Hasibeder WR
    Anesth Analg; 2001 Jul; 93(1):7-13. PubMed ID: 11429329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD; Jung R; Fish DN; MacLaren R
    Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial.
    Torgersen C; Dünser MW; Wenzel V; Jochberger S; Mayr V; Schmittinger CA; Lorenz I; Schmid S; Westphal M; Grander W; Luckner G
    Intensive Care Med; 2010 Jan; 36(1):57-65. PubMed ID: 19756505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac performance during vasopressin infusion in postcardiotomy shock.
    Dünser MW; Mayr AJ; Stallinger A; Ulmer H; Ritsch N; Knotzer H; Pajk W; Mutz NJ; Hasibeder WR
    Intensive Care Med; 2002 Jun; 28(6):746-51. PubMed ID: 12107681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin during cardiopulmonary resuscitation and different shock states: a review of the literature.
    Krismer AC; Dünser MW; Lindner KH; Stadlbauer KH; Mayr VD; Lienhart HG; Arntz RH; Wenzel V
    Am J Cardiovasc Drugs; 2006; 6(1):51-68. PubMed ID: 16489848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin effective in reversing catecholamine-resistant vasodilatory shock.
    Lim TW; Lee S; NG KS
    Anaesth Intensive Care; 2000 Jun; 28(3):313-7. PubMed ID: 10853217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of vasopressin infusion on hemodynamics, liver and renal function in pediatric patients.
    Jerath N; Frndova H; McCrindle BW; Gurofsky R; Humpl T
    Intensive Care Med; 2008 Jul; 34(7):1274-80. PubMed ID: 18350274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of vasopressin for treating vasodilatory shock and cardiopulmonary arrest.
    Scroggin RD; Quandt J
    J Vet Emerg Crit Care (San Antonio); 2009 Apr; 19(2):145-57. PubMed ID: 19691565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study.
    Dünser MW; Mayr AJ; Ulmer H; Knotzer H; Sumann G; Pajk W; Friesenecker B; Hasibeder WR
    Circulation; 2003 May; 107(18):2313-9. PubMed ID: 12732600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients.
    Jeon Y; Ryu JH; Lim YJ; Kim CS; Bahk JH; Yoon SZ; Choi JY
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):952-6. PubMed ID: 16675238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of vasopressin.
    Daga MK; Singh KJ; Kumar N
    J Assoc Physicians India; 2006 May; 54():376-80. PubMed ID: 16909734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin necrosis after a low-dose vasopressin infusion through a central venous catheter for treating septic shock.
    Kim EH; Lee SH; Byun SW; Kang HS; Koo DH; Park HG; Hong SB
    Korean J Intern Med; 2006 Dec; 21(4):287-90. PubMed ID: 17249516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock.
    van Haren FM; Rozendaal FW; van der Hoeven JG
    Chest; 2003 Dec; 124(6):2256-60. PubMed ID: 14665508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of vasodilatory shock: defining the role of arginine vasopressin.
    Dunser MW; Wenzel V; Mayr AJ; Hasibeder WR
    Drugs; 2003; 63(3):237-56. PubMed ID: 12534330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous arginine vasopressin infusion in refractory vasodilatory shock: a clinical study.
    Agrawal A; Singh VK; Varma A; Sharma R
    Indian J Pediatr; 2012 Apr; 79(4):488-93. PubMed ID: 21922300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.